Oncolytics Biotech Inc T.ONC

New Press Release - Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep

Updated plan follows PanCAN's strategic re-evaluation of the Precision PromiseSM ProgramPanCAN US$5 million grant provides support for new GOBLET mFOLFIRINOX arm to proceed as plannedNew Phase 3 strategy provides significant value-creation opportunitiesSAN DIEGO, CA and CALGARY, AB, Nov. 9, 2023 ...read article.

[Lesalpes29]

Hahaha Matt! Nothing more after all this time! Time is running dummy! Get back to mute mode...

[13X2413]

So that explains what has been causing the hammering of this share price. The PanCan deal is now on the back burner(dead) and Onc is now forced to focus something else.  I may me wrong, but this doesn't bode well for the near term. Scared to look at the pre-opening. 

[Azzak34]

We're pushing for Accelerated Approval right now!!! The Phase 3 trial is the confirmatory trial, read Matt's choice of words.  The anal results just put us in a "hole" new category :) 

[canadafan]

The update on anal resukts, being three out of 4 branches of the Goblet study being positive, i# great news. The PanCan re- evaluation? confusing at best. essentially no new trials until they reevaluate their programs. Onc to proceed with phase 3 regardless. & still recieve tge $5 million for additional phase 2 arm. big picture, I see a buyout from Roche a lot sooner than previously

[jh1970]

No money to run phase 3, buyout or the end.

[13X2413]

I smell dilution.